8-K: Chicago Atlantic BDC Reports Record Q1 2026 Results
Quarterly Report
Chicago Atlantic BDC announced record financial results for Q1 2026, with total gross investment income of $16.7 million and net investment income of $10.0 million, driven by a growing portfolio and a differentiated lending strategy.
Summary
- Chicago Atlantic BDC (LIEN) reported record financial results for the first quarter ended March 31, 2026.
- Total gross investment income reached $16.7 million, and net investment income was $10.0 million, or $0.44 per share.
- The total investment portfolio grew to $364.0 million at fair value, an increase of $30.7 million from the prior quarter.
- Net asset value (NAV) per share was $13.33, a slight increase of $0.03 from the previous quarter.
- The company funded seven new portfolio companies with $93.9 million in aggregate par value, a record amount.
- No loans were on non-accrual status as of March 31, 2026.
- A dividend of $0.34 per share was declared for the quarter ending June 30, 2026.
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a strong positive report, with record results, significant portfolio growth, and strategic positioning for future capital raises, despite some unrealized depreciation.
Positives
- Record total gross investment income of $16.7 million.
- Record net investment income of $10.0 million, or $0.44 per share.
- Record funding of $93.9 million to seven portfolio companies, including three new borrowers.
- Investment portfolio grew to a new peak of $364.0 million at fair value.
- Net asset value per share increased to $13.33.
- Weighted average yield on debt investments remained strong at 15.8%.
- No loans on non-accrual status, indicating strong credit quality.
- The company filed a shelf registration statement to potentially raise up to $500 million, enhancing financial flexibility.
Negatives
- Net change in unrealized depreciation on investments was $1.4 million, reflecting widening credit spreads.
- Total liabilities increased significantly to $68.9 million from $38.6 million in the prior quarter, largely due to a higher revolving line of credit balance.
Risks
- The broader private credit markets have experienced pressure regarding portfolio performance, dividend coverage concerns, and interest rate uncertainty.
- Net change in unrealized depreciation on investments of $1.4 million reflects the impact across the portfolio of widening credit spreads during the quarter.
- Forward-looking statements involve substantial risks and uncertainties, including factors beyond the Company's control that could cause actual results to differ materially.
Future Outlook
The company is confident in its differentiated model of self-originating direct lending opportunities to cannabis and lower middle-market companies. The recent federal policy change to reschedule medical cannabis is expected to enhance borrower credit quality and improve industry fundamentals. A shelf registration statement has been filed to provide enhanced financial flexibility for portfolio growth.
Management Comments
- Chicago Atlantic BDC delivered record results this quarter, demonstrating the benefits of our differentiated strategy.
- While the broader private credit markets have experienced pressure regarding portfolio performance, dividend coverage concerns and interest rate uncertainty, Chicago Atlantic BDC has become stronger this quarter, funding a record level of $93.9 million of investments and growing the portfolio to a new peak of $364.0 million.
- We also generated record net investment income per share of $0.44, while maintaining a weighted average yield of 15.8%, well above the industry averages.
- We remain confident in the opportunity set for our differentiated model of self-originating direct lending opportunities to cannabis and lower middle market companies.
- A recent policy change by the Federal government to reschedule medical cannabis represents the most significant federal policy shift in decades and is a notable policy inflection point that we expect will enhance borrower credit quality and improve industry fundamentals over time.
- We remain conservative in our strategic execution but are encouraged by the recent momentum.
Industry Context
StockSavvy.ai notes that Chicago Atlantic BDC's focus on the cannabis and lower middle-market sectors, coupled with its senior-secured lending strategy, positions it to capitalize on opportunities arising from regulatory shifts and market inefficiencies. The company's ability to maintain a high portfolio yield (15.8%) while navigating broader private credit market pressures highlights its differentiated approach.
Comparison to Industry Standards
- Chicago Atlantic BDC's weighted average portfolio yield on debt investments of 15.8% is significantly higher than the US High Yield Index (7.3%), the US Leveraged Loan Yield Index (8.8%), and the average portfolio yield of public BDCs (10.8%).
- The company's GAAP leverage ratio of 17.9% is lower than the average for public BDCs (25.5%).
- Non-accruals at cost for LIEN are 0.0%, which is lower than the average for public BDCs (3.4%).
- LIEN's total 2nd lien, sub & equity exposure is 1.3%, significantly lower than the average for public BDCs (23.0%).
Stakeholder Impact
- Shareholders are positively impacted by record net investment income per share and a declared dividend of $0.34 per share.
- The shelf registration statement provides potential for future growth, which could benefit shareholders.
- The company's strategy of lending to cannabis and lower middle-market companies may impact employees and customers of those businesses through access to capital.
Next Steps
- The company will host a conference call and live audio webcast on May 14, 2026, at 9:00 a.m. Eastern Time to discuss Q1 2026 financial results.
- The shelf registration statement, once effective, will enable the company to access capital markets for portfolio growth.
- The company will continue to focus on self-originating direct lending opportunities in the cannabis and lower middle-market sectors.
Key Dates
| Date | Description |
|---|---|
| 2025-11-01 | Federal legislation tightened the hemp definition, effectively banning intoxicating hemp-derived THC with a one-year wind-down period. |
| 2026-03-31 | End of the first quarter for which financial results are reported. |
| 2026-04-01 | DOJ reclassified medical-use and FDA-approved cannabis products from Schedule I to Schedule III. |
| 2026-05-11 | Company filed a shelf registration statement with the SEC to issue up to $500 million of securities. |
| 2026-05-14 | Date of the press release announcing Q1 2026 financial results and the date of the Form 8-K filing. |
| 2026-06-26 | Record date for the dividend payable on July 10, 2026. |
| 2026-06-29 | New hearing process begins to consider broadening rescheduling of cannabis to include adult-use. |
| 2026-07-10 | Date the declared dividend of $0.34 per share is payable to shareholders. |
Recommendation
holdThe company reported record results and a strong portfolio yield, with positive future outlook due to regulatory changes in the cannabis sector. However, the unrealized depreciation and increased leverage warrant a cautious 'hold' rating until the capital raise is utilized and its impact is assessed.
Keywords
Chicago Atlantic BDC, Business Development Company, BDC, Specialty Finance, Cannabis Lending, Private Credit, Q1 2026 Earnings, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.